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SUMMARY
Three novel dehydrated wheat/rice cereal functional products with an addition of 
well documented probiotic Bifidobacterium animalis ssp. lactis BB-12® (BB-12®) were de-
veloped in Podravka factory  for the infants older than 4 months: instant rice cereal, in-
stant rice cereal with fruits and instant wheat cereal with vanilla. Notably, the number of 
viable BB-12® cells in each of the novel products was higher than the required minimal 
number of probiotic cells per gram of product (106 CFU/g) during the storage period of 
106 weeks. Therefore, BB-12® strain recovery and genome stability were evaluated by 
strain-specific polimerase chain reaction and amplified fragment length polymorphism 
fingerprinting analysis. Further aim was to evaluate the influence of these three different 
cereal food matrices on specific probiotic properties of BB-12® strain in vitro. Applied food 
matrices positively influenced the survival in the simulated conditions of the gastroin-
testinal tract and antagonistic activity against undesirable microorganisms, while no in-
fluence on auto- and coaggregation ability of B. animalis ssp. lactis BB-12® was observed. 
Adhesion to extracellular matrix proteins and intestinal epithelial Caco-2 cells together 
with antibacterial activity emphasized competitive pathogen exclusion from Caco-2 cells 
by probiotic strain BB-12®.
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INTRODUCTION
Probiotics are living microorganisms that, when administered in adequate amounts, 
confer a health benefit to the host (1). Probiotic bacteria are mostly members of Lactoba-
cillus and Bifidobacterium genera. These genera are members of indigenous microbiota of 
humans and animals and are generally recognized as safe (GRAS) (2). An important probi-
otic property of bifidobacteria is the production of short-chain fatty acids (SCFAs), as well 
as breakdown of carbohydrates and proteins in the intestinal tract. It is believed that this 
feature is most valued because of the proven clinical effects of Bifidobacterium animalis 
ssp. lactis BB-12® strain, in the prevention of diarrhoea caused by antibiotics, Clostridium dif-
ficile and rotavirus (3). Strain BB-12® is one of the world's best-studied probiotic strains (4).
Desirable feature of probiotic strains is efficient binding to the intestinal epithelial cells 
and production of antimicrobial substances. However, to perform beneficial effects on 
human health, probiotics need to be applied in the high cell count. They have to survive 
food processing and gastrointestinal tract (GIT) transit, which is challenging for the food 
industry to find new alternatives for their incorporation in food. Probiotic functionality 
may even be enhanced after their application in food, since interaction with food ingre-
dients can protect bacterial cells during the passage through the GIT (5).
The emergence of allergic diseases in infants is on a rise, often attributable to exces-
sive hygiene resulting with insufficient exposure to microbes that are crucial in the de-
velopment of the immune system (6). Intestinal microbiota is acquired by birth and there 
is significant difference in the gut microbiota composition of naturally delivered infants 
compared to infants delivered by caesarean section. Intestinal bacteria of the babies born 
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by caesarean section originate from the surface of the moth-
er’s skin, instead of mother’s vagina (7). Namely, intestinal 
microbiota of breast-fed infants mainly contains Bifidobac-
terium species, whereas intestinal microbiota of infants fed 
by industrial substitutes have higher number of Bacteroides, 
Clostridium and Lactobacillus bacteria. The intestinal microbi-
ota affects the immune system and the lack of bifidobacteria 
is associated with the food allergies, e.g. Kirjavainen et al. (8) 
demonstrated the reduction of the allergic eczema by strain 
BB-12®, while Taipale et al. (9) showed increased resistance to 
the pathogens by BB-12®. Bifidobacteria beneficially affect 
health by indigestion of carbs not absorbed in the upper GIT, 
by producing vitamins, SCFAs and antimicrobial metabolites 
(10). Therefore, B. animalis ssp. lactis BB-12® is commonly add-
ed probiotic strain to the infant formulas.
Previously, Hajduk et al. (11) investigated the probiotic 
properties of BB-12® strain in cereal flakes enriched with inu-
lin and the results showed increased viable cell count of lac-
tic acid bacteria (LAB), while the number of enterobacteria 
and sulphite-reducing clostridia in the faecal and intestinal 
microbiota of mice was reduced. Cereal flakes and inulin had 
a protective role and promoted the BB-12® strain survival un-
der simulated GIT conditions. The main objective of this re-
search is to determine the influence of three different matri-
ces, i.e. instant rice cereal, instant rice cereal with fruits – apple, 
peach, pear and apricot, and instant wheat cereal with vanilla 
on probiotic properties of BB-12®. Genotypic characterisation 
and the functionality of BB-12® in the products was verified 
through the research of antibiotic susceptibility, survival in 
simulated GIT conditions, deconjugation activity to bile salts, 
assimilation of cholesterol, microbial antagonism and bacte-
riocinogenic activity. In addition, adhesion properties of BB- 
-12® strain on Caco-2 cell line and proteins of extracellular ma-
trix and competitive exclusion of test-microorganisms were 
investigated.
MATERIALS AND METHODS
Dehydrated wheat/rice cereal products with a probiotic 
BB-12® 
We evaluated the functional properties of probiotic strain 
Bifidobacterium animalis ssp. lactis BB-12® incorporated in de-
hydrated wheat/rice cereal products developed on a pilot 
scale, namely instant rice cereal, instant rice cereal with fruit 
and instant wheat cereal with vanilla, produced in Podrav-
ka d.d., Koprivnica, Croatia. Novel probiotic products contain 
0.25 % (m/m) PROBIO-TEC® BB-12® strain (Chr. Hansen Holding 
A/S, Hoersholm, Denmark) in lyophilized form. Dehydrated in-
stant rice cereal contains rice flour, vitamins (thiamine mon-
onitrate, riboflavin, pyridoxine hydrochloride, l-ascorbic acid, 
dl-alpha tocopherol acetate, folic acid and nicotinamide) and 
iron(III) pyrophosphate. Dehydrated instant rice cereal with 
fruit contains follow-on formulae, rice grits, partially deminer-
alized whey powder, inulin, maltodextrin, fruits (apple, peach, 
pear and apricot mash), skimmed milk, calcium lactate and 
vitamins (β-carotene, thiamine mononitrate, riboflavin, pyr-
idoxine hydrochloride, l-ascorbic acid, colecalciferol, dl-al-
pha tocopherol acetate, folic acid and niacin). Dehydrated in-
stant wheat cereal with vanilla contains follow-on formulae, 
wheat grits, partially demineralized whey powder, skimmed 
milk, maltodextrin, wheat flour, starch, vitamins (β-carotene, 
thiamine mononitrate, riboflavin, pyridoxine hydrochloride, 
l-ascorbic acid, colecalciferol, dl-alpha tocopherol acetate, fo-
lic acid and niacin) and vanilla flavouring.
Survival of probiotic strain BB-12® in novel products dur-
ing 24 months of storage at room temperature was deter-
mined by the agar plate method using transgalctosylated 
oligiosaccharide (TOS)-propionate agar (Merck, Darmstadt, 
Germany). The plates were incubated anaerobically for 72 h 
at 37 °C.
PCR and AFLP identification of BB-12® in novel products
BB-12® colonies grown on TOS-propionate agar plates 
were collected and grown in MRS broth medium (Biolife, Mi-
lan, Italy) for 18 h. DNA was isolated from 1.5 mL of BB-12® 
overnight cultures using the method of Gardiner et al. (12), 
while polymerase chain reaction (PCR) with specific primers 
for Bifidobacterium species was performed as described by 
Kaufmann et al. (13). The extracted DNA was then used as a 
template in subsequent PCR amplifications, which were per-
formed in a total volume of 50 μL in a DNA Mastercycler (Ep-
pendorf Scientific Inc., Hamburg, Germany). PCR mixtures 
contained 4 ng/μL of template DNA, 10×Taq polymerase buf-
fer (Gibco BRL Life Technologies, Burlington, Ontario, Canada), 
each deoxynucleoside triphosphate (Thermo Fisher Scientific, 
Waltham, MA, USA) at a concentration of 0.2 μM, 1 U of Taq 
DNA polymerase (Boehringer GmbH, Mannheim, Germany), 
and each primer at a concentration of 1 μM. A Bifidobacteri-
um genus-specific target sequence in the V9 variable region 
of the 16S rRNA (5'-CGGGTGCTGCCCACTTTCATG-3') was used 
to identify BB-12®. DNA was amplified for 30 cycles by using 
the following conditions: denaturation at 94 °C for 40 s, an-
nealing at 52 °C for 1 min, and polymerization at 72 °C for 3 
min. The initial denaturation was performed at 95 °C for 5 min, 
and a final extension step at 72 °C for 8 min was also used. The 
PCR products (10 μL) were analysed on a 1.5 % (w/V) agarose 
(Fisher Scientific, Fair Lawn, NJ, USA) gel with 1×TAE buffer (40 
mM Tris acetate, 1 mM EDTA, pH=8) and ethidium bromide 
staining. An O’GeneRuler 100-bp DNA ladder (Thermo Fisher 
Scientific, Rochester, NY, USA) and λ HindIII were used as mo-
lecular size standards. Gels were run for approx. 2 h at 55 V, 
and the DNA was visualized by MiniBisPro (DNR Bio-Imaging 
Systems LTD, Jerusalem, Israel).
Bacterial strain identification was confirmed by DNA fin-
gerprinting technique amplified fragment length polymor-
phism (AFLP) provided by an independent institution Bel-
gian Coordinated Collection of Microorganisms (BCCMTM)/
LMG Bacteria Collection Identification Service, Ghent Univer-
sity, Ghent, Belgium (14). Clustering of the patterns was done 
using the Dice coefficient and the UPGMA algorithm (15).
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Survival of BB-12® in simulated gastric and  
small intestinal juice
Cumulative effect of the simulated gastric and small intes-
tinal juice on the survival of BB-12® strain was investigated ac-
cording to Hajduk et al. (11). Samples were pure lyophilized cul-
ture of BB-12® and BB-12® in instant rice cereal, instant rice cereal 
with fruit and instant wheat cereal with vanilla. Simulated gastric 
juice was prepared by suspending pepsin (3 g/L; Sigma-Aldrich, 
Merck, St. Louis, MO, USA) in a sterile sodium chloride solution 
(0.5 %; Kemika, Zagreb, Croatia) and pH was adjusted to 2.5 with 
concentrated HCl (Kemika). Simulated small intestinal juice was 
prepared by suspending pancreatin (1 g/L; Fluka Biochemica, 
Buchs, Switzerland) and bile salts (1.5 g/L oxgall; Difco, Detroit, 
MI, USA). Samples were taken every hour during the treatment 
with gastric juice and every 2 h during treatment with small in-
testinal juice. The viable cell count was determined after 24 h of 
anaerobic incubation at 37 °C. The results are expressed in log 
CFU/mL as the mean of three replicates.
Quantitative determination of the bile salt hydrolase 
activity and cholesterol assimilation
The ability of probiotic strains to hydrolyze bile salts is 
included among the criteria for probiotic strain selection, 
therefore the bile salt hydrolase activity was determined by 
quantification of the amount of cholic acid liberated from con-
jugated bile salt sodium taurocholate (Difco, Detroit, MI, USA) 
using solvent extraction method during 24 h of incubation. 
The BB-12® capability to assimilate cholesterol (AppliChem, 
Darmstadt, Germany) in MRS broth was evaluated by the mod-
ified o-phthalaldehyde method (16). The amount of the choles-
terol was determined in the supernatant, in the washing buffer, 
where precipitated cholesterol was redissolved, and in the cell 
extract after cell disruption to obtain assimilated cholesterol 
after 24 h of incubation in MRS containing 3 mg/mL of oxgall 
(Difco) and 0.2 mg/mL of cholesterol (17). Samples for these 
methods were: lyophilized pure BB-12® strain and wheat/rice 
cereal product (instant rice cereal with or without fruit and in-
stant wheat cereal with vanilla), cultivated in MRS broth. Ab-
sorbance was read at 540 nm using an automatic microplate 
reader TECAN INFINITE® 200 PRO (Männedorf, Switzerland). A 
standard curve of absorbance versus cholesterol concentra-
tions was generated and finally the cholesterol assimilated by 
probiotic BB-12® samples was calculated as percentage accord-
ing to the following equation:
Cholesterol assimilation=((c0 – c24)–c(precipitated)/c0)·100 /1/
where c0 is cholesterol concentration at 0 h, c24 is cholesterol 
concentration after 24 h and c(precipitated) is the concentra-
tion of cholesterol precipitated in the solution.
Antibiotic susceptibility testing
Antibiotic susceptibility was examined by agar disc diffu-
sion method using test discs (Oxoid Ltd., Basingstoke, UK) and 
E test strips (M.I.C.EvaluatorTM, Oxoid Ltd) according to Leboš 
Pavunc et al. (18). Briefly, overnight grown culture of BB-12®, 
diluted to give viable cell count of approx.108 CFU/mL, was in-
oculated into 12 mL of MRS agar. Next, susceptibility test disks 
(Oxoid, Ltd) of eight different antibiotics were placed asepti-
cally on the MRS agar and incubated for 24 h. The diameters of 
the inhibition zones were measured and an average of three 
readings was calculated.
Antimicrobial activity
Antimicrobial activity was tested by agar-well diffusion as-
say performed according to Kos et al. (19) and by microplate 
growth inhibition assay described by Beganović et al. (20) with 
slight modifications. Samples for agar-well diffusion were 
twofold dilutions of lyophilized pure culture of BB-12® strain 
and wheat/rice cereal products instant rice cereal, instant rice 
cereal with fruit and instant wheat cereal with vanilla. Antag-
onistic activity of BB-12® strain, evaluated by the agar-well 
diffusion assay, was expressed as the diameter of the inhibi-
tion zones. The antimicrobial activity of the supernatants ob-
tained after cultivation of lyophilized pure culture of BB-12® 
strain and from wheat/rice cereal products, instant rice cereal 
with or without fruit and instant wheat cereal with vanilla in 
MRS broth was determined by microplate growth inhibition 
assay. Settings for the growth curve/turbidity analysis using 
an Infinite 200 PRO multimode plate reader Infinite 200 PRO 
(Tecan Inc, Morrisville, NC, USA) were as follows: absorbance 
measurement wavelength 620 nm, number of flashes 1, tem-
perature range 35–37 °C, shaking amplitude 3 mm, shake du-
ration (orbital normal) 10 s, kinetic interval 3600 s, and total 
measurement time 6 h. The Falcon® 96-well flat-bottom plate 
with low evaporation lid (Falcon, Corning Inc., Durham, NC, 
USA) was used to prevent evaporation of the liquid and well-
-to-well contamination. The obtained A620 nm values were plot-
ted against time and used to calculate the antibacterial activ-
ity of the samples against test microogranisms.
Autoaggregation and coaggregation assays
 Autoaggregation assays were performed as described 
previously (21). Bacteria were grown in MRS broth, harvest-
ed by centrifugation at 1771×g for 10 min in Eppendorf cen-
trifuge 5804R (Hamburg, Germany), and washed twice with 
phosphate-buffered saline (PBS; pH=7.4; Gibco, Paisley, Scot-
land, UK). Washed bacterial cells were resuspended in PBS to 
an adjusted absorbance (A600 nm) of 1 and autoaggregation was 
determined over 5 h using microplate reader LKB 5060-006 
(LKB Vertriebs GmbH, Vienna, Austria). The autoaggregation 
percentage is expressed as:
 Autoaggregation=(1–(At/A0)) ·100 /2/ 
where At represents the absorbance at time t=1, 2, 3, 4 or 5 h 
and A0 the absorbance at t=0 h. The percentage of coaggrega-
tion was calculated using the equation described by Kos et al. 
(19), where x and y represent each of the two bacterial strains 
in the experiment, and (x+y) their mixture:
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Samples for these methods were BB-12® strains isolat-
ed from lyophilized pure culture and from wheat/rice cereal 
products; instant rice cereal with or without fruit and instant 
wheat cereal with vanilla.
Adhesion experiments
Caco-2 cells were seeded onto 48-well plate in a final volume 
of 230 μL of Dulbecco's modified medium/Ham's F-12 (DMEM/
F12; Capricorn Scientific GmbH, Ebsdorfergrund, Germany) sup-
plemented with 10 % fetal bovine serum (FCS; Thermo Fisher 
Scientific, Rochester, NY, USA) and l-glutamine. After formation 
of a monolayer, the Caco-2 cells were routinely inoculated with 
bacterial suspensions at multiplicity of infection (MOI) 10 and 
100 for 1, 4 and 12 h with slow agitation at 2 rpm (Hi/Lo Rocker; 
IBI Scientific, Dubuque, IA, USA). In brief, 2.3·109 CFU/mL BB-12® 
bacteria were washed twice with PBS at 3000×g for 15 min in Ep-
pendorf centrifuge 5804R at room temperature. After discarding 
the supernatant, the pellet was suspended in 500 μL of 5 μM of 
fluorescent label 5(6)-carboxyfluorescein N-hydroxysuccinimide 
ester (CFSE; BioLegend, San Diego, CA, USA) in PBS and incubat-
ed in thermomixer (Eppendorf Scientific Inc, Hamburg, Germa-
ny) at 37 °C for 60 min. BB-12® bacterial cells were then washed 
twice with PBS and 0.5 % BSA (Sigma Aldrich, Merck, Schnelldorf, 
Germany). The remaining pellet was suspended in 1 mL of me-
dium and the appropriate volume of the suspension was added 
to each well. After incubation period, the non-adherent bacteria 
were washed twice with PBS and the cells with adherent bacte-
ria were fixed in 4 % formaldehyde, pH=7.4, at 37 °C for 15 min. 
After fixation and subsequent washing with PBS, the cells were 
stained with 4',6-diamidino-2-phenylindole (DAPI; Thermo Fisher 
Scientific, Rochester, NY, USA). Images of Caco-2 and BB-12® cells 
were acquired using an EVOS FLc Cell Imager (Thermo Fisher Sci-
entific, Waltham, MA, USA). In parallel, to evaluate the potential 
effect of the indigestible resistant starch, available in human co-
lon, on BB-12® adhesion, binding of the BB-12® to Caco-2 cell line 
in the presence of the two different starch mass fractions 1 and 
10 % was assessed.
Human fibronectin (BD BioCoat; BD Biosciences, Erembo-
degem, Belgium), type I collagen (Biocoat, Coventry, UK) and 
laminin (BD BioCoat; BD Biosciences) immobilised on 96-well 
flat-bottom plates were used in experiments of BB-12® binding 
to immobilised extracellular matrix proteins according to the 
method described by Uroić et al. (22). Bifidobacterium BB-12® cell 
suspension (A620 nm=1.0), grown until late exponential phase, 
was incubated overnight at 4 °C. After removing the nonad-
hered bacteria by three washes with 200 mL of PBS and 0.05 
% Tween 20, the plates were dried and the adhered bacteri-
al cells were detected by staining with 1 mg/mL crystal violet 
(Merck, Darmstadt, Germany) for 45 min. After washing, the col-
ourant was released with 50 mM sodium citrate buffer (pH=4.0) 
and the absorbance at 620 nm was measured by a microplate 
reader (LKB Vertriebs GmbH). The effect of protease treatment 
was performed by incubating bacterial cells at A620 nm=1.0 in 1 
mL of PBS with 100 mg/mL of proteinase K (Invitrogen™, Carls-
bad, CA, USA) at 37 °C for 1 h. After incubation, the proteinase 
was inactivated by the addition of 1 mM phenylmethylsulfonyl 
fluoride (PMSF) followed by three washes with 1 mM PMSF in 
PBS. Bacterial cells were resuspended in PBS to A620 nm=1.0 and 
used for binding assays. Control bacterial cells were handled 
exactly as the treated bacterial cells but without the addition 
of proteinase K. All the experiments were repeated three times 
and the results were expressed as mean values of three inde-
pendent trials±standard deviation (S.D.).
Pathogen exclusion assay on Caco-2 cell line
To assess the ability of the BB-12® strain to exclude enter-
opathogens Salmonella enterica serovar Typhimurium FP1 and 
Escherichia coli 3014, exclusion and adhesion assay on Caco- 
-2 cell line was performed as described by Uroić et al. (22) and 
Banić et al. (23). The Caco-2 cells were grown in 24-well flat-bot-
tom tissue culture plates (Falcon, Corning Inc) until confluent 
differentiated monolayers were obtained. Before competitive 
exclusion assay, the Caco-2 monolayers were carefully rinsed 
three times with PBS (pH=7.4). Routinely cultivated BB-12® and 
enteropathogenic bacterial cells were harvested and suspend-
ed in PBS (pH=7.4) to reach A620 nm=1 (approx. 10
9 CFU/mL). Af-
ter 1 h of incubation of BB-12® at 37 °C, Caco-2 monolayers were 
gently washed three times with PBS (pH=7.4). Next, the enter-
opathogenic cells were added and Caco-2 cells were incubat-
ed for additional 1 h at 37 °C. Both 1.0-mL aliquots of the en-
teropathogen or DMEM were used as the control. Nonadhered 
bacterial cells were removed by washing with PBS (pH=7.4). The 
Caco-2 cells were then lysed by the addition of 0.25 % (V/V) Tri-
ton X-100 (AppliChem) at 37 °C for 10 min in order to collect the 
adherent bacterial cells, and the total numbers of viable adher-
ing BB-12®, E. coli and S. Typhimurium were determined by spot 
plate method on MRS, Rapid (Biorad, Dubai, United Arab Emir-
ates) and XLD (Biolife, Milano, Italy) agar plates, respectively.
Statistical analyses
All experiments were performed in triplicate and the re-
sults were expressed as mean values of three independent tri-
als±standard deviation. Statistical significance was appraised 
by one-way analysis of variance. Pairwise differences between 
the mean values of groups were determined by the Tukey’s 
honestly significant difference (HSD) test for pairwise compar-
isons (24). The differences between treatments that were sub-
sequently described as significant were determined at p<0.05.
RESULTS AND DISCUSSION
In order to exert the health promoting effects, probiotic 
preparations should contain live bacterial cell counts high-
er than 106/g of the product, as recommended by FAO/WHO 
(25,26). Therefore, the initial number of BB-12® cells in wheat/
Food Technol. Biotechnol. 57 (2) 147-158 (2019)
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wheat/rice cereal product expiry date (Fig. 1a). Besides stor-
age conditions, the product manufacturing process strongly 
impacts the viability of the bacterial strains, influencing pro-
biotic stability and properties. Therefore, to confirm the BB-
12® strain presence and strain purity after its application in the 
rice cereal products was set up to 2.71·107 CFU/g. Moreover, 
the number of viable probiotic cells determined in the 106th 
week was above the required minimum counts for probiot-
ic products (106/g of product). This storage period is actual-
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developed products, validated genotypic methods were em-
ployed. Probiotic strain BB-12® was isolated from the respec-
tive products on selective TOS-propionate agar medium. For 
rapid quality control of the strain, in a culture or in the product, 
single bacterial colonies were collected for the strain identifi-
cation and characterisation, where lyophilized pure culture of 
BB-12® strain was used as a control. PCR method performed 
with Bifidobacterium species-specific primers confirmed the 
presence of a single-stranded DNA, either from the bacterial 
culture recovered from the instant rice cereal product or from 
freeze-dried pure culture, which corresponded to the bacte-
ria of the Bifidobacterium genus (Fig. 1b). Next, reidentification 
of the bacterial strain isolated from the instant rice cereal was 
carried out by DNA fingerprinting AFLP method provided by 
BCCM Identification Service, University of Ghent (Ghent, Bel-
gium). Cluster analysis of the AFLP™ DNA fingerprint of the 
isolated DNA sample (assigned ID 15042) with the reference 
AFLP™ DNA fingerprints of the lactic acid bacteria taxa, includ-
ing bifidobacteria as currently available in BCCM database (14), 
confirmed the isolated bacterial culture from the novel prod-
uct as Bifidobacterium animalis (Fig. 1c). Additionally, since the 
Fig. 1. The presence of viable Bifidobacterium animalis ssp. lactis BB-12® cells in dehydrated wheat/rice cereal product is confirmed: a) during 
long term storage for 106 weeks. The results are mean values of three independent experiments and error bars represent standard deviations, b) 
by polymerase chain reaction (PCR) with specific primers for Bifidobacterium strains. S=standard λ HindIII and Gene ruler 100 bp, 1=lyophilized 
BB-12® culture, 2=BB-12® culture isolated from instant rice cereal, and c) by AFLPTM DNA fingerprinting profile of B. animalis ssp. lactis BB-12® (ID 
15042) compared with BCCM reference and phylogenetically related Bifidobacterium species (type strains are indicated with T) (BCCMTM/LMG 
Identification Service, Ghent University, Ghent, Belgium)
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species B. animalis encompasses two subgroups: subgroup I 
containing the type strains of B. animalis ssp. lactis, and sub-
group II, containing the type strain of B. animalis ssp. anima-
lis, as demonstrated by AFLP™ (Fig. 1c), it was important to 
group the presumptive BB-12® isolate from the product. The 
obtained dendrogram clearly demonstrated that the applied 
BB-12® is genetically related to the strains of subgroup I B. an-
imalis ssp. lactis.
According to EFSA (European Food Safety Authority), bac-
terial products intended for use either as food or feed addi-
tives must be examined to establish the susceptibility of the 
component strain(s) to antibiotics (27). In the case of Bifido-
bacterium, the minimum inhibitory concentration of each of 
the antibiotics: ampicillin, vancomycin, gentamicin, strepto-
mycin, erythromycin, clindamycin, tetracycline and chloram-
phenicol must be determined. Antibiotic susceptibility of the 
BB-12®, both as lyophilized pure culture or a culture applied 
to the products was monitored by the agar diffusion method 
and E test, and their profiles coincided, confirming a lack of 
the influence of the product matrices on the antibiotic sus-
ceptibility of the BB-12®. The results were in correlation with 
EFSA recommendation, except for aminoglycosides, which 
are probably inactivated in acidic medium due to the BB-12® 
production of acetic and lactic acid (data not shown) (28).
The influence of instant rice cereal with or without fruit 
and instant wheat cereal with vanilla matrices on the BB-12® 
survival in the GIT was evaluated. The main obstacle for sur-
viving in the GIT conditions is low pH of the stomach, bile 
salts and digestive enzymes. Therefore, the survival of BB-12® 
strain, as lyophilized pure culture and culture from instant 
rice or wheat cereal products, was examined in simulated 
GIT conditions (Fig. 2). Number of BB-12® cells in all wheat/
rice cereal products at the end of the study was up to 2.5 log-
arithmic units higher than the number of live cells in the ly-
ophilized culture. Therefore, instant wheat/rice cereal ma-
trices have protective effect when exposing BB-12® cells to 
rigorous stress conditions that are present in the GIT. Howev-
er, there was no significant difference observed in the BB-12® 
cell survival in simulated GIT among the three matrices. This 
is in accordance with the results of Jungersen et al. (4), who 
have summarised investigations related to exposure of Bifido-
bacterium strains to low pH, gastric juice and bile salts and re-
ported that BB-12® exhibited higher gastric acid and bile toler-
ance than other Bifidobacterium strains. Similarly, dos Santos 
et al. (29) in the recently published work observed a higher 
survival of BB-12® when applied in table spreads as food ma-
trix than of BB-12® culture alone, when exposed to similar in 
vitro gastrointestinal simulated conditions. High BB-12® acid 
tolerance is probably due to the induction of H+-ATPase, an 
enzyme complex involved in maintaining intracellular pH ho-
meostasis in bacteria (4).
The high concentration of bile salts in the intestine, due to 
the high inhibition activity against Gram-positive microorgan-
isms, is an obstacle for the probiotic bacteria to colonize ileum 
terminalis. One of the mechanisms of bacterium resistance to 
bile salts is their deconjugation by hydrolase enzyme. There-
fore, cell growth of BB-12® strain, as lyophilized pure culture 
and culture in wheat/rice cereal products, in the presence of 
bile salts was examined. The deconjugation of sodium salt of 
taurocholic acid as the most common bile salt in the human 
bile was also tested by quantitative determination of the bile 
salt hydrolase activity (Table 1). Additionally, cholesterol as-
similation of BB-12® strain was examined in both lyophilized 
pure culture and in the culture recovered from wheat/rice ce-
real products after 24 h of cultivation in the presence of bile 
salts (data not shown). Probiotic strain BB-12® probably pro-
duces bile acid hydrolase, since it exhibits deconjugation ac-
tivity during the growth in a nutrient medium supplemented 
with 2 mg/mL sodium taurocholate. This mechanism is poten-
tially responsible for the defence action of BB-12® cells against 
bile salts. BB-12® produces bile salt hydrolase, an enzyme that 
catalyses bile salt deconjugation and consequently provides 
an advantage for the cell as it allows a quick response to high 
bile salt concentrations and thus facilitates the viable passage 
from the small intestine to the large intestine (4). Next, no 
significant difference was observed among the isolates from 
three cereal products, although BB-12® cells isolated from the 
instant rice cereal with fruit exhibited a slightly higher bile 
acid hydrolase activity (Table 1). After 24 h of BB-12® growth 
in the presence of cholesterol and bile salts, the cells from ly-
ophilized pure culture removed about 55 % of the cholester-
ol from the nutrient medium. Approx. 30 % of the cholester-
ol was present in the extract of the cells, indicating not only 
the cholesterol coprecipitation with the deconjugated bile 
salts (approx. 25 %), but also its assimilation. Conversely, BB-
-12® cells from instant rice cereal assimilated up to 50 % of 
total cholesterol, while during the growth of probiotic 45 % 
of cholesterol was precipitated in solution. BB-12® cells from 
the instant rice cereal with fruit removed about 90 % of the 
cholesterol from the nutrient medium. As 48 % cholesterol 
was found in the extract of the cells, it means that this prod-
uct matrix increased the assimilation of cholesterol by 18 %. 
Finally, BB-12® cells from the instant wheat cereal with vanilla 
removed 82 % of the cholesterol from the nutrient medium. 
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Fig. 2. Survival of Bifidobacterium animalis ssp. lactis BB-12® in the 
dehydrated wheat/rice cereal products exposed to simulated gas-
trointestinal tract conditions (arrow indicates the change in in vitro 
conditions: after 2 h in simulated gastric fluid at pH=2.0 followed by 
4-hour incubation in simulated intestinal fluid at pH=8.3). The results 
are expressed as mean values of three independent experiments and 
error bars represent standard deviations
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As 43 % cholesterol was found in the extract of the cells, it 
means that this product matrix increased the assimilation of 
cholesterol by 13 %. As previously commented, bile salts dis-
organize the structure of the cell membrane and trigger DNA 
damage if Gram-positive bacteria do not have intrinsic resist-
ance mechanisms against their deleterious action. Bifidobac-
teria can progressively adapt to the presence of bile salts and 
probably have evolved specific defence mechanisms, which 
include action of a variety of proteins devoted to the efflux 
of bile salts or protons, to modify sugar metabolism or to 
prevent protein misfolding. Bile response is a multifactorial 
phenomenon connecting processes addressed towards de-
toxification of bile and counteracting the effect on bacterial 
structures. Besides, protection against oxidative damage and 
global glycolytic reorganizations are other mechanisms that 
might be employed to counteract cellular damage caused by 
bile salts (30).
Pathogen exclusion is important aspect of probiotic mode 
of action. It is facilitated through the production of inhibito-
ry substances, toxin degradation, competition for nutrients 
and sites of adherence, and induction of immune responses 
(4). The inhibition of Gram-negative bacteria is mainly due to 
the production of common metabolites such as organic acids, 
while different peptides and bacteriocins are of importance 
in the inhibition of Gram-positive microorganisms. Bacteri-
ocins are antimicrobial peptides with activity spectra against 
closely related Gram-positive bacteria, while the producing 
cells are immune to their action. Therefore, antibacterial ac-
tivity of BB-12® strain, as purified lyophilized cultures and cul-
ture in wheat/rice cereal products, was examined towards 
test-microorganisms that are potential food contaminants 
and pathogens, using the agar-well diffusion assay and the 
turbidimetric method (Fig. 3). Higher inhibition activity was 
obtained with cells in the pure lyophilized culture, which may 
be caused by difficulty of antimicrobial metabolite diffusion 
trough the production matrix (data not shown). Significant 
difference in the antimicrobial activity of the supernatants 
from the instant rice cereal and instant wheat cereal with va-
nilla against test microorganism Bacillus subtlis ATCC 6633 and 
supernatant from the instant rice cereal against test microor-
ganism S. Typhimurium FP1 was shown. Still, the antimicro-
bial activity of these supernatants appeared to be more effi-
cient, by 6 %, than the supernatant of pure lyophilized culture 
(Fig. 3). Several mechanisms have been proposed for bifido-
bacteria inhibiting pathogens including strains of Escherichia, 
Salmonella, Bacillus and Listeria: lowering of pH due to organ-
ic acid production, inhibitory activity of undissociated mole-
cules of organic acids, competition for nutrients or adhesion 
sites, stimulation of immunosystem and production of bacte-
riocins (31,32). According to Cheikhyoussef et al. (33), BB-12® 
strain produces bacteriocin Bifilact BB-12® with antimicrobi-
al activity against S. aureus, E. coli, S. enterica serovar Typhi-
murium and Listeria sp. Bifidobacteria showed high growth 
rates in rich synthetic media but also grew in simple media 
containing only lactose, free amino acids and some nucleo-
tides, vitamins and minerals because the control of magnesi-
um, manganese and iron levels is essential for optimal growth 
of bifidobacteria or bacteriocin production as a result of nu-
tritional stress or induction. In addition, many strains of bi-
fidobacteria can utilize complex biopolymers to improve cell 
growth and production of antimicrobials. These are mainly 
carbohydrates metabolized by bifidobacteria, but not by the 
host or other bacteria and are often used as prebiotics (34). 
Finally, dietary fibre has also been found to be effective in pro-
moting intestinal growth of bifidobacteria and influence their 
antimicrobial production, so infant food matrices used here 
may have a potential to induce bacteriocin production. How-
ever, some bacteriocins may affect probiotic cultures so this 
must be considered when selecting bacteriocin-producing 
strain for inclusion in functional foods (35–37). Furthermore, 
besides bacteriocins, some other proteins, encoded by genes 
present in B. animalis ssp. lactis genome, which are involved in 
Table 1. Growth (A620 nm) and bile salt hydrolase activity of Bifidobacterium animalis ssp. lactis BB-12® from wheat/rice cereal products after 24 h of 
cultivation at 37 °C in MRS broth supplemented with 2 mg/mL of sodium salt of taurocholic acid (TCA) 
Sample A620 nm γ(cholic acid)/(g/L) w(deconjugated TCA)/%
BB-12® (0.40±0.01)a (0.26±0.02)b (13.0±1.5)ab
BB-12® (IRC) (0.42±0.03)a (0.27±0.01)b (13.5±0.7)ab
BB-12® (IRCF) (0.41±0.07)a (0.5±0.02)a (15.0±1.3)a
BB-12® (IWC) (0.39±0.05)a (0.25±0.03)b (13.0±0.5)b
IRC=instant rice cereal, IRCF=instant rice cereal with fruit, IWC=instant wheat cereal with vanilla. The results are expressed as mean value±standard 
deviation of three separate experiments. Different letters in superscript indicate statistically significant difference among the data across the 
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Fig. 3. Antibacterial activity of cell-free supernatants of Bifidobacte-
rium animalis ssp. lactis BB-12® with and without wheat/rice cereal 
products after 24 h of incubation against test microorganisms: 1=S. 
aureus 3048, 2=S. aureus K-11, 3=E. coli 3014, 4=S. enterica serovar 
Typhimurium FP1, 5=B. cereus TM2, 6=B. subtilis ATCC 6633. The re-
sults are expressed as mean value of three independent experiments 
and error bars represent standard deviation. *Significantly different 
(p<0.01) from the BB-12® without cereal product
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the BB-12® adaptation to and survival in the human GIT, could 
also be related to its antimicrobial potential. Specifically, two 
paralogues encoding putative N-acetylmuramidases, which 
are probably involved in the degradation of enteropathogen 
bacterial cell wall components, are present in the BB-12® ge-
nome, as well as genes encoding putative cell surface pro-
teins that could be involved in the interactions with human 
epithelial cells and consequently in competitive exclusion un-
desirable bacteria. Moreover, Bifidobacterium species, besides 
the production of lactate, also synthesise acetate, one of the 
major SCFA, important for growth and differentiation of colo-
nocytes, which accounts for more than 80 % of the SCFA pro-
duction in the infant gut, and is a key metabolite in the early 
establishment of colonization resistance by preventing infec-
tions with enteropathogens (30). Indirectly, through a meta-
bolic cross-feeding, where the metabolic products of a species 
or group of species provide growth substrates for other popu-
lations, production of acetate by Bifidobacterium sustains the 
growth of other favourable species that have a potential to 
inhibit enteropathogens.
Adhesion to intestinal epithelial cells is important for the 
colonization of probiotic strains in the GIT since it prevents 
their removal due to intestinal peristalsis and enables a com-
petitive advantage over other bacteria. Prerequisite for the 
adhesion of probiotic strains to intestinal epithelial cells is 
the autoaggreation. Autoaggregation of BB-12® cells from ly-
ophilized pure culture and in the wheat/rice cereal products 
was examined (Fig. 4). Namely, probiotic bacteria that demon-
strate coaggregation efficiency together with antimicrobial 
activity could represent an obstacle for the colonization of 
pathogenic microorganisms. In addition, coaggregation with 
other LAB that tolerate low pH could promote colonization 
of bifidobacteria in the intestine. Therefore, coaggregation of 
BB-12® strain with LAB representatives, e.g. Lactobacillus hel-
veticus M92 and Enterococcus faecium L3, and with test micro-
organisms Salmonella Typhimurium FP1 and E. coli 3014 was 
investigated (Table 2). Autoaggregation and coaggregation 
of BB-12® was monitored during 5 h. Although autoaggrega-
tion of lyophilized pure BB-12® culture was higher in the first 
4 h of incubation than the autoaggregation of BB-12® cultures 
recovered from wheat/rice cereal products at the 5th hour, 
which was the last hour of experiment, the autoaggregation 
percentage (>60 %) among all tested samples did not signifi-
cantly differ. Coaggregation properties of lyophilized pure BB-
-12® culture and cultures isolated from instant rice cereal and 
instant wheat cereal with vanilla were equally efficient either 
with Lactobacillus helveticus M92 or Enterococcus faecium L3 
or the applied test microorganisms. The difference is observed 
with Salmonella Typhimurium FP1, where coaggregation with 
lyophilized pure BB-12® culture was about 10 % higher than 
with BB-12® isolated from instant rice cereal with fruit. Coag-
gregation ability of BB-12® from all the samples with two LAB 
was more obvious, and it increased approx. 20 % compared 
with test microorganisms. Autoaggregation and coaggrega-
tion prevent the colonization of pathogens on surfaces, as 
they are involved in the second phase of biofilm formation. 
Numerous investigations have verified the beneficial effect of 
probiotic strains in biofilm form, including e.g. increased re-
sistance to temperature or gastric pH (38). Falagas and Makris 
(39) proposed using probiotic LAB strains as excellent candi-
dates to form protective biofilms and to even be part of daily 
cleaning products to lower the incidence of pathogenic mi-
croorganisms. Accordingly, Gómez et al. (40) reported the po-
tential of probiotic LAB biofilms to control L. monocytogenes, 
S. Typhimurium and E. coli O157:H7 biofilm formation.
Immobilised mucin and monolayer culture of Caco-2 cells 
are model systems commonly used for the testing of probiot-
ic strain adhesion (23). Hence, Caco-2 cells were used to test 
the adherence capacity of probiotic strain BB-12®. The adhe-
sion ability of the probiotic BB-12® strain to anchor and col-
onize human epithelial intestinal cell monolayer was inves-
tigated using Caco-2 cell line. Fig. 5a shows representative 
staining of Caco-2 nuclei (blue) together with adhered BB-12® 
cells (green) using EV in instant wheat cereal with vanilla OS 
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Fig. 4. Comparison of the autoaggregation ability of Bifidobacterium 
animalis ssp. lactis BB-12® cells with and without wheat/rice cereal 
products resuspended in phosphate buffered saline (pH=7.2). The 
results are expressed as mean values of three independent experi-
ments and error bars represent standard deviations
Table 2. Coaggregation ability of Bifidobacterium animalis ssp. lactis BB-12® with and without wheat/rice cereal products after 5 h of incubation 
in phosphate-buffered saline (pH=7.2) at room temperature
Microorganism
Coagreggation/%
BB-12® BB-12® (IRC) BB-12® (IRCF) BB-12® (IWC)
Lactobacillus helveticus M92 (53.7±1.3)az (50.51±0.8)bz (55.32±2.2)az (49.56±0.5)bz
Enterococcus faecium L3 (41.4±0.5)by (42.50±0.7)by (45.87±0.8)ay (37.84±1.2)cy
Salmonella Typhimurium FP1 (34.5±1.1)ax (30.58±0.9)bx (25.67±1.3)cx (35.72±0.8)ax
Escherichia coli 3014 (23.5±1.3)cw (25.63±0.7)bw (27.45±0.8)ax (23.43±1.1)cw
IRC=instant rice cereal, IRCF=instant rice cereal with fruit, IWC=instant wheat cereal with vanilla. Results are mean value±standard deviation of 
three separate experiments. abcStatistically significant difference (p<0.05) within the same column; wxyzstatistically significant difference (p<0.05) 
within the same row 
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Fig. 5. Fluorescence microscopy images of Bifidobacterium animalis ssp. lactis BB-12® adhesion to Caco-2 cell monolayer: a) BB-12®=BB-12® bacte-
rial cells (green fluorescence), nuclei/BB-12®=dual fluorescence overlays of Caco-2 cell nuclei (blue fluorescence) and BB-12® bacterial cells (green 
fluorescence). Fluorescence overlays of Caco-2 cell nuclei (blue fluorescence) with adhered BB-12® bacterial cells (green fluorescence) at different 
seeding density: b) multiplicity of infection 10, and c) multiplicity of infection 100, after 1, 4 and 12 h of incubation at 20× magnification
to the Caco-2 cell monolayer at MOI 10 (Fig. 5b) and MOI 100 
(Fig. 5c) after 1, 4 and 12 h incubation is shown. The high-
er number of BB-12® cells adhered to Caco-2 cell monolayer 
with the increase of MOI at longer incubation time. Accord-
ingly, the highest BB-12® adhesion capacity was achieved at 
MOI 100 and after 12 h of incubation, when autoaggregates 
of BB-12® cells were observed and the ratio of adhered probi-
otic bacterial cells to Caco-2 cells was 35:100 (Fig. 5c). This is 
in line with a high aggregation capability of BB-12® as shown 
in Fig. 4. Next, in order to evaluate the potential effect of the 
indigestible resistant starch, available in colon, on BB-12® ad-
hesion, the binding of the BB-12® to Caco-2 cell line was as-
sessed with the addition of two different starch mass frac-
tions (1 and 10 %). The difference in BB-12® binding to Caco-2 
cells was not significant in the presence (number of adhered 
BB-12® cells was 2.95·107 or 2.84·107 CFU/mL, respectively) or 
absence (4.43·107 CFU/mL) of two different starch mass frac-
tions (data not shown).
The adhesion of BB-12® cells to human collagen, fibronec-
tin and laminin (Fig. 6) was analysed, since extracellular ma-
trix (ECM) is a complex structure composed of the respective 
proteins, surrounding the intestinal epithelial cells (41). BB-12® 
adhesion to fibronectin and collagen was more effective than 
to laminin, whereas no significant difference was observed 
between fibronectin and collagen. Protein nature of adhe-
sive receptors on the bacterial cell surface was tested by prior 
proteinase K treatment of the examined cells. The adhesion 
mediators to ECM are probably of nonproteinaceous nature, 
implying that other surface molecules are probably involved 
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the BB-12® adhesion capacity was significantly interrupted after 
proteinase K treatment of the bacterial cells. Namely, the pre-
dicted functions encoded by bifidobacterial genome sequenc-
es provide genetic evidence that bifidobacteria are very well 
adapted to colonize the (human) GIT (42). The results, hence, 
could be correlated with the presence of capA and capB genes 
encoding putative collagen adhesion proteins in BB-12® ge-
nome. Additionally, although slight decrease of adhesion was 
observed after the proteinase K treatment in fibronectin bind-
ing experiment, the fbp gene encoding a fibronectin-binding 
protein was also present in BB-12® genome. Both collagen- and 
fibronectin-binding proteins are involved in the interactions 
with human epithelial cells (43,44). Collectively, Bifidobacteri-
um species possess important strategies that ensure their col-
onization at high abundance in the infant gut, prevention of 
the growth of competing species that are disturbing host mi-
crobiota balance and promotion of immune development (32).
The capability of probiotic bacteria to adhere to the human 
epithelial cells or mucosa is due to their ability to block the ad-
hesion sites for pathogens (45). The effect is associated with the 
properties of the probiotic strain and the pathogen adherence 
ability. Using Caco-2 cell line, the number of adherent BB-12® 
cells prior to adding the pathogens and the competence to 
exclude the adhesion of pathogens was examined. Approxi-
mately 5·106 CFU/mL of 3·109 CFU/mL added BB-12® cells ad-
hered to Caco-2 cells. Exclusion assay was executed in order to 
assess whether or not the preincubated probiotic strain is able 
to prevent pathogen adhesion to epithelial cells. The results 
signify that the adherence of BB-12® strain to Caco-2 cell line 
reduces the attachment of S. Typhimurium FP1 for approx. 1.5 
log CFU/mL (p<0.05), whereas the invasion of E. coli 3014 cells 
was not noticeably discernible (approx. 0.71 log CFU/mL) (data 
not shown). Considering the beforehand obtained adhesion 
pattern, proved by live cell imaging microscope together with 
exclusion capacity, and coaggregation with examined path-
ogens, BB-12® probiotic strain has an impact on the adhesion 
ability and could downsize the negative effects of both strains, 
S. Typhimurium FP1 and E. coli 3014.
CONCLUSIONS
PCR with Bifidobacterium strain-specific primers and AFLP 
DNA fingerprints confirmed the presence of BB-12® strain in 
newly developed wheat/rice cereal infant products, where 
the determined probiotic bacterial counts were above 106 
CFU/g, as requested for probiotic products by FAO/WHO. 
Significantly higher viable cell counts were observable after 
probiotic cell exposure in simulated gastrointestinal condi-
tions when probiotic culture BB-12® was used in processed 
wheat/rice cereal products than of lyophilized pure culture. 
Aggregation ability, adhesion to extracellular matrix proteins 
and intestinal epithelial Caco-2 cells together with antibac-
terial activity emphasized competitive exclusion of strains S. 
Typhimurium FP1 and E. coli 3014 from Caco-2 cells by probi-
otic strain BB-12®. Wheat/rice cereal products enriched with a 
lyophilized probiotic culture positively influenced cholesterol 
assimilation by BB-12® strain. Altogether, the results suggest 
reciprocal beneficial effects resulting from the positive influ-
ence of the pilot-scale processed wheat/rice cereal products 
on the specific probiotic properties of BB-12® strain, while the 
incorporation of the BB-12® brought potential added func-
tional value to a novel product.
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